Abstract Original Article
The records were screened for codes K70-K77, and a total of 1860 patients were initially screened. Of these, 1263 had CLD, cirrhosis or HCC. Three hundred and one were excluded due to insufficient data or unclear diagnosis. A total of 962 patient records were then analysed for the study.
Definitions used in the study 1 . Chronic hepatitis: Transaminitis for more than 6 months 2. Cirrhosis of liver: Diagnosis based on clinical, biochemical and radiological that included triple-phase computed tomography in the presence or absence of varices 3. Decompensated cirrhosis: Cirrhosis with ascites, gastrointestinal bleed, hepatic encephalopathy and jaundice (combination of any 2) 4. HCC: Classical imaging findings on contrast-enhanced computed tomography (CECT)/magnetic resonance imaging abdomen (early arterial enhancement with early washout) with or without a rise in alpha-fetoprotein levels.
The study cohort included patients with chronic hepatitis (transaminitis beyond 6 months) and cirrhosis of the liver (confirmed by CECT abdomen) with or without 
results
The study population consisted of 150 cases of CLD with HCC and 812 controls (CLD with no HCC).
Comparing cases with controls, we observed that CLD patients with HCC were significantly older (P < 0.0001) with a male preponderance, but no gender predisposition (P = NS) [ Table 1 ]. Alcohol per se or in combination with other factors such as HBV and HCV were significantly associated with CLD (P < 0.0001) but not for HCC. However, HBV (P < 0.0001), HCV (P < 0.0001) and NASH (P = 0.03) were independently associated with HCC.
Comorbidity and hepatocellular carcinoma
The overall prevalence of DM in patients with CLD was 31.9%, more significant amongst cases than in controls (50.7% vs. 28.7%) (P < 0.0001) and for a significant duration (10.6 vs. 3.8 years; P < 0.03).
Amongst the cases, comorbid conditions such as hypertension and CAD and diabetes in combination with hypertension and CAD were also more frequent among cases (P = 0.0001) [ Table 2 ].
The OR of developing HCC in CLD was higher for DM compared to HBV and HCV infections [ Table 3 ]. The OR for HCC was highest for DM with hypertension and/or CAD at 4.69 (3.19-6.88, P < 0.0001), highlighting the impact of metabolic syndrome in development of HCC.
Age-adjusted incidence rates are summarised in Table 4 and presented in Figure 1 . Table 4 shows that incidence of DM increased with increasing age in the cases. The incidence of HCC was highest in the age group of 51-60 years, followed by 61-70 years. Higher incidence of both DM and HCC was noted in the age groups of 81-90 years, 51-60 years and 41-50 years. Although we did find linear correlation between increasing HCC and DM with age, the numbers were too small, particularly at extreme age group, to draw firm conclusions.
dIscussIon
The present study from South India highlights that DM and other constituents of metabolic syndrome such as hypertension and CAD are significantly more common in CLD patients with HCC. DM is of prolonged duration and is a risk factor increasing the neoplastic potential of CLD.
DM has been identified as an independent risk factor for the HCC in western studies. [8] [9] [10] [11] Analysis of 2061 patients with HCC showed a significant increase risk in the development of HCC (OR 2.87, 95% CI: 2.49-3.3) in the presence of DM regardless of the existence of other risk factors. Moreover, the authors also reported a significant positive interaction between obesity and HCV (P < 0.0001) for HCC.
DM with cirrhosis demonstrated the highest risk for HCC (RR = 82.25, 95% CI: 76.84-94.58). [12] A recent surveillance, epidemiology and end results (SEER)-Medicare data analysis showed that the OR of DM for HCC was 2.9.
[13] The Me-Can survey from Norway, Sweden and Austria examining more than 5,00,000 subjects reported a relative risk of 2.13 (95% CI: 1.55-2.94) for DM in the development of HCC. [14] Hypertension is an important component of the metabolic syndrome. Very few studies examined the relationship of HCC with hypertension. SEER-Medicare data analysis reported that OR of hypertension for HCC was 2.22. [13] A single-centre study also showed that among 209 non-B non-C-HCC patients, 38% had hypertension, and 11% had dyslipidaemia. [15] The present study is a large retrospective analysis highlighting the role of DM in pathogenesis of HCC in the Indian setting for the first time. However, it has a few limitations such as retrospective analysis; selection bias as our centre is a liver transplant centre; no data regarding lipid profile, anthropometry and treatment details; few cases in extremes of age groups and so effect of age on HCC not clearly noted; cases and controls unmatched in age. conclusIon It is extremely important for the scientific community, especially the diabetologists and practicing family and general physicians to be aware of not only the neurovascular complications in their patients but also the associated risk of HCC in long-standing diabetics. Is HCC a natural onslaught of long-standing diabetes, or is the combination of comorbid states or co-existence of HBV and HCV that enhances the risk for HCC needs exploration by prospective studies. Do anti-diabetic drugs enhance the risk for HCC also needs to be addressed. Finally, all DM patients must be screened for hepatotropic viruses such as HBV and HCV and non-alcoholic steatohepatitis for stratifying the risk factors mentioned in a large cohort.
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